CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Jun 28, 2022. (Total: 3910 publications since 2011)

All HLBS RCH FHH Equity Diabetes Rare Cancer COVID-19 ND PGx PI Environmental dataset

Filtered By: Select to fine-tune your search CDC Author Year CDC Organization Journal

Records 1-10 (of 10 Records)

Query Trace: all>>Steven G F Wassilak[CDC Author]
Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2020-June 2021. Mary M Alleman, Jaume Jorba, Elizabeth Henderson, Ousmane M Diop, Shahzad Shaukat, Mohamed A Traoré, Eric Wiesen, Steven G F Wassilak, and Cara C Burns MMWR. Morbidity and mortality weekly report 2021 70(49) 1691-1699 Similar articles in PubMed DOI:10.15585/mmwr.mm7049a1
Progress Toward Polio Eradication - Worldwide, January 2017-March 2019. Sharon A Greene, Jamal Ahmed, S Deblina Datta, Cara C Burns, Arshad Quddus, John F Vertefeuille, and Steven G F Wassilak MMWR. Morbidity and mortality weekly report 2019 68(20) 458-462 Similar articles in PubMed DOI:10.15585/mmwr.mm6820a3
Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2017-2018. Jaymin C Patel, Ousmane M Diop, Tracie Gardner, Smita Chavan, Jaume Jorba, Steven G F Wassilak, Jamal Ahmed, and Cynthia J Snider MMWR. Morbidity and mortality weekly report 2019 68(13) 312-318 Similar articles in PubMed DOI:10.15585/mmwr.mm6813a4
Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response. Dominika A Kalkowska, Mark A Pallansch, Steven G F Wassilak, Stephen L Cochi, and Kimberly M Thompson Vaccine 2021 5 Similar articles in PubMed DOI:10.1016/j.vaccine.2021.04.061
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain. Dominika A Kalkowska, Mark A Pallansch, Amanda Wilkinson, Ananda S Bandyopadhyay, Jennifer L Konopka-Anstadt, Cara C Burns, M Steven Oberste, Steven G F Wassilak, Kamran Badizadegan, and Kimberly M Thompson Risk analysis : an official publication of the Society for Risk Analysis 2020 Nov Similar articles in PubMed DOI:10.1111/risa.13622
Updated Characterization of Post-OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV Restart. Dominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, Stephanie D Kovacs, Steven G F Wassilak, and Kimberly M Thompson Risk analysis : an official publication of the Society for Risk Analysis 2020 Jul Similar articles in PubMed DOI:10.1111/risa.13555
Update on Vaccine-Derived Poliovirus Outbreaks - Democratic Republic of the Congo and Horn of Africa, 2017-2018. Chukwuma Mbaeyi, Mary M Alleman, Derek Ehrhardt, Eric Wiesen, Cara C Burns, Hongmei Liu, Raimi Ewetola, Lerato Seakamela, Rennatus Mdodo, Modjirom Ndoutabe, Pierre Kandolo Wenye, Yogolelo Riziki, Peter Borus, Christopher Kamugisha, and Steven G F Wassilak MMWR. Morbidity and mortality weekly report 2019 Mar (9) 225-230 Similar articles in PubMed DOI:10.15585/mmwr.mm6809a2
Surveillance Systems to Track Progress Toward Polio Eradication - Worldwide, 2015-2016. Edmond F Maes, Ousmane M Diop, Jaume Jorba, Smita Chavan, Rudolph H Tangermann, and Steven G F Wassilak MMWR. Morbidity and mortality weekly report 2017 Apr (13) 359-365 Similar articles in PubMed DOI:10.15585/mmwr.mm6613a3
Surveillance Systems to Track Progress Toward Polio Eradication - Worldwide, 2014-2015. Cynthia J Snider, Ousmane M Diop, Cara C Burns, Rudolph H Tangermann, and Steven G F Wassilak MMWR. Morbidity and mortality weekly report 2016 (13) 346-51 Similar articles in PubMed DOI:10.15585/mmwr.mm6513a3
Detection of vaccine-derived polioviruses in Mexico using environmental surveillance. Alejandra Esteves-Jaramillo, Concepción F Estívariz, Silvia Peñaranda, Vesta L Richardson, Jesús Reyna, Diana L Coronel, Veronica Carrión, Jose M Landaverde, Steven G F Wassilak, Elda E Pérez-Sánchez, Irma López-Martínez, Cara C Burns, and Mark A Pallansch J. Infect. Dis. 2014 Nov 1. 210 Suppl 1S315-23 Similar articles in PubMed DOI:10.1093/infdis/jiu183